An official website of the European Union How do you know?      
European Commission logo
JRC Publications Repository Menu

Retention studies in polymer vesicles of recoiling atoms as a result of alpha decay

cover
Alpha radionuclide therapy has a great potential for cancer treatment as shown by a large number of pre-clinical and clinical studies. In vivo generators capable of delivering a highly efficient cascade of alpha particles are also steadily gaining importance. Currently, 225Ac is the most potential radionuclide that can be used as an in vivo generator, providing four alpha particles with a total energy of 28 MeV. However, the alpha emitting daughter nuclides of 225Ac may deviate from their intended destination due to recoil effects and cause unwanted toxicity to healthy tissue. According to previous simulation studies1 we developed polymer vesicles (polymersomes) to retain recoil atoms subsequent to alpha decay.
2013-06-21
Oak Ridge National Laboratory
JRC82797
Language Citation
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 
Show metadata record  Copy citation url to clipboard  Download BibTeX
Items published in the JRC Publications Repository are protected by copyright, with all rights reserved, unless otherwise indicated. Additional information: https://ec.europa.eu/info/legal-notice_en#copyright-notice